Oracle at $140: Buying Negative FCF Never Looked So Good
Oracle just burned through billions in free cash flow while a $664 billion backlog sits waiting to convert, and Wall Street analysts are betting the gap between those two numbers holds the key to a 67% return.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Oracle (NYSE:ORCL | ORCL Price Prediction) trades at $142.50. Cash burn today funds AI capacity customers have already signed up to use.
Oracle built its name on database software and enterprise applications. Cloud now drives the story, reaching 60% of total revenue last quarter. The stock is down 50.16% over the past year from a 52-week high of $319.46. Investors pulled back after free cash flow came in at negative $23.7 billion in fiscal 2026 and negative $5.4 billion last quarter.
A $664 Billion Backlog Is Converting Into Revenue
Q1 fiscal 2027 revenue rose 29.6% to $19.345 billion, with cloud infrastructure revenue up 121% to $7.39 billion. Remaining performance obligations hit $664 billion, with management expecting “around half of our RPO to convert into sales over the next 36 months.” GPU utilization was 97.9%, and renewed capacity commanded a 20% premium.
Oracle booked over $30 billion in new AI contracts requiring no extra cash, mostly structured as prepayments or bring-your-own-hardware deals. Operating cash flow rose 184% to $23.1 billion. Guidance calls for at least $90 billion in fiscal 2027 revenue and $8.10 in non-GAAP EPS. The stock trades at 18x forward earnings with a PEG ratio of 0.807.
A Ballooning Capex Bill Strains the Balance Sheet
Capex reached $28.5 billion in a single quarter, and management expects $90 to $95 billion for the full year. When asked when free cash flow turns positive, management said, “We haven’t given a particular timeframe on that yet.” Interest expense rose 55% to $1.4 billion, and total liabilities stand at $236.06 billion. A completed $20 billion at-the-market equity program diluted existing shareholders.
Software license revenue fell 15%. The backlog is concentrated in a few large AI customers, and new sites in New Mexico and Wisconsin still face regulatory approval and power hurdles (the same power and cooling constraint we broke down across seven AI infrastructure suppliers: here). Shares fell 13% after the Q2 fiscal 2026 revenue miss.
Investor Day Could Settle the Margin Debate
Management expects gross margins to flatten as expansion finishes and will detail margins at its upcoming Investor Day. Shares trade under the 200-day moving average of $162.89 and near the 50-day average of $143.59. A firm free cash flow timeline or smooth Vera Rubin delivery would strengthen the bull case. A capex increase without matching prepayments would strengthen the bearish thesis.
Wall Street Sees 67% Upside in a Stock Cut in Half
The average analyst target is $237.97, meaning 67% upside. Of 43 analysts covering the stock:
- Strong Buy: 7
- Buy: 28
- Hold: 7
- Sell: 1
Oracle trades at 22 times trailing earnings. Over the past year the stock lost 50.16% while the S&P 500 gained 15.01%. Year to date, Oracle is down 26.28% and the index is up 12.86%.
Negative Free Cash Flow Is Funding a Contracted Growth Engine
At $142.50, Oracle’s investment case rests on cash flow quality and backlog conversion.
Negative free cash flow exaggerates the problem. After prepayments, Q1 cash capex was $18 billion, below operating cash flow. Management caps full-year net cash capex at 70 billion. Hilary Maxson said scaled projects deliver “a free cash flow conversion ratio of something like 100% to post-tax EBITDA.”
RPO conversion drives upside. Q2 guidance calls for 65-71% cloud growth. Co-founder Larry Ellison also canceled his plan to sell Oracle stock.
The thesis breaks if renewal pricing falls, utilization drops, or the prepayment share shrinks and forces more debt. Those three signals are the key metrics to monitor each quarter.
At 18x forward earnings, Oracle carries a $664 billion signed backlog, with prepayments already offsetting part of its cash burn.
Contact [email protected] for any questions or corrections.
Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.
Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.
At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.
